PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler chemo before cell therapy shows promise for tough melanoma
Disease control CompletedThis study tested a lower dose of chemotherapy given before infusing a patient's own tumor-fighting immune cells (lifileucel) for melanoma that has spread or can't be removed. Eleven adults with advanced melanoma took part. The goal was to see if the milder chemo prep still allow…
Matched conditions: PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug combo shows promise against advanced melanoma before surgery
Disease control CompletedThis study tested whether giving a combination of drugs (vemurafenib, cobimetinib, and atezolizumab) before surgery could help patients with high-risk stage III melanoma. The goal was to see if the treatment could shrink or eliminate tumors before surgical removal. The trial invo…
Matched conditions: PATHOLOGIC STAGE IIIC CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 16:01 UTC